Pharmacological characterization of tegaserod at the wild type and 124Cys variant of the human 5-HT1B receptor

Pharmacogenetics and Genomics

Volumn 21, Issue 7, 2011, Pages 432-435

  Haenisch, Britta ^a   Bönisch, Heinz ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

constipation predominant irritable bowel syndrome; human coronary artery; sumatriptan tegaserod

Indexed keywords

FOLIC ACID; HOMOCYSTEINE;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FEMALE; FOLATE METABOLISM; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING; UNITED STATES;

RATTUS;

EID: 79959773636     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/FPC.0b013e3283469f1d     Document Type: Article

References (15)

1. Kaumann AJ, Parsons AA, Brown AM. Human arterial constrictor serotonin receptors. Cardiovasc Res 1993; 27:2094-2103. (Pubitemid 24034717)
2. Kaumann AJ, Frenken M, Posival H, Brown AM. Variable participation of 5-HT1-like receptors and 5-HT2 receptors in serotonin-induced contraction of human isolated coronary artery. 5-HT1-like receptors resemble cloned 5-HT1Db receptors. Circulation 1994; 90:1141-1153.
3. MaassenVanDenBrink A, Reekers M, Bax WA, Ferrari MD, Saxena PR. Coronary side-effect potential of current and prospective antimigraine drugs. Circulation 1998; 98:25-30. (Pubitemid 28312075)
4. Nöthen MM, Erdmann J, Shimron-Abarbanell D, Propping P. Identification of genetic variation in the human serotonin1Db receptor gene. Biochem Biophys Res Commun 1994; 205:1194-1200.
5. Brüss M, Bönisch H, Bühlen M, Nöthen MM, Propping P, Göthert M. Modified ligand binding to the naturally occurring Cys-124 variant of the human serotonin 5-HT1B receptor. Pharmacogenetics 1999; 9:95-102. (Pubitemid 29176728)
6. Kiel S, Brüss M, Bönisch H, Göthert M. Pharmacological properties of the naturally occurring Phe124-Cys variant of the human 5-HT1B receptor. Changes in ligand binding, G-protein coupling and second messenger formation. Pharmacogenetics 2000; 10:655-666.
7. Mehrotra S, Vanmolkot KR, Frants RR, Van den Maagdenberg AM, Ferrari MD, MaassenVanDenBrink A. The phe-124-Cys and A-161T variants of the human 5-HT1B receptor gene are not major determinants of the clinical response to sumatriptan. Headache 2007; 47:711-716. (Pubitemid 46733718)
8. Camilleri M. Review article: tegaserod. Aliment Pharmacol Ther 2001; 15:277-289. (Pubitemid 32187551)
9. Quigley EM,Wald A, Fidelholtz J, Boivin M, Pecher E, Earnest D. Safety and tolerability of tegaserod in patients with chronic constipation: pooled data from two phase III studies. Clin Gastroenterol Hepatol 2006; 4:605-613.
10. Appel-Dingemanse S. Clinical pharmacokinetics of tegaserod, a serotonin 5HT(4) receptor partial agonist with promotile activity. Clin Pharmacokinet 2002; 41:1021-1042. (Pubitemid 35246780)
11. Public Health Advisory: Tegaserod maleate (marketed as Zelnorm) (2007). Available at: http://www.fda.gov/Drugs/DrugSafety/ PostmarketDrugSafetyInformationforPatientsandProviders/ DrugSafetyInformationforHealthcareProfessionals/PublicHealthAdvisories/ ucm051284.htm [Accessed 30 March 2007].
12. Pasricha PJ. Desperately seeking serotonin: a commentary on the withdrawal of tegaserod and the state of drug development for functional and motility disorders. Gastroenterology 2007; 132:2287-2290. (Pubitemid 46890891)
13. Chan KY, De Vries R, Leijten FP, Pfannkuche HJ, Van den Bogaerdt AJ, Danser AH, MaassenVanDenBrink A. Functional characterization of contractions to tegaserod in human isolated proximal and distal coronary arteries. Eur J Pharmacol 2009; 619:61-67.
14. Chen C, Okayama H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 1987; 7:2745-2752.
15. Verheggen R, Werner I, Lü cker A, Brüss M, Göthert M, Kaumann AJ. 5-Hydroxytryptamine-induced contraction of human temporal arteries coexpressing 5-HT2A receptors and wild-type or variant (Phe124Cys) 5-HT1B receptors: increased contribution of 5-HT1B receptors to the total contractile amplitude in arteries from Phe124Cys heterozygous individuals. Pharmacogenet Genom 2007; 16:601-607.